Enjoy your
FREE PREVIEW which shows only 2022 data and 25 documents. Contact
Patent Forecast for full access.
AI Biotech/Diagnostics: General Diagnostics
Search All Applications in AI Biotech/Diagnostics: General Diagnostics
Application US20180353094
Published 2018-12-13
Apparatus, Systems And Methods For Predicting, Screening And Monitoring Of Encephalopathy/delirium
The disclosed apparatus, systems and methods relate to predicting, screening, and monitoring for delirium. Systems and methods may include receiving one or more signals from one or more sensing devices; processing the one or more signals to extract one or more features from the one or more signals; analyzing the one or more features to determine one or more values for each of the one or more features; comparing at least one of the one or more values or a measure based on at least one of the one or more values to a threshold; determining a presence, absence, or likelihood of the subsequent development of delirium for a patient based on the comparison; and outputting an indication of the presence, absence, or likelihood of the subsequent development of delirium for the patient.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1. A system for patient delirium screening, comprising:
a. a handheld screening device comprising a housing; b. at least two sensors configured to record one or more brain signals and generate one or more values; c. a processor; and d. at least one module configured to:
i. perform spectral density analysis on the one or more values; and
ii. output data presenting an indication of the presence, absence, or likelihood of the subsequent development of encephalopathy.
- 11. A system for evaluating the presence of encephalopathy, comprising:
a. at least two sensors configured to record one or more brain frequencies; b. a processor; c. at least one module configured to:
i. compare brain wave frequencies over time;
ii. perform spectral density analysis on the brain wave frequencies to establish a ratio;
iii. compare the ratio against an established threshold; and
iv. output data presenting an indication of the presence, absence, or likelihood of the subsequent development of encephalopathy.
- 17. A handheld device evaluating the presence, absence, or likelihood of the subsequent development of encephalopathy in a patient, comprising:
a. a housing; b. at least one sensor configured to generate at least one brain wave signal; c. at least one processor; d. at least one system memory; e. at least one program module configured to perform spectral density analysis on the at least one brain wave signal and generate patient output data; and f. a display configured to depict the patient output data.
